 <h1>Alfuzosin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>More frequently reported side effects include:</b> dizziness.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to alfuzosin: oral tablet extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, alfuzosin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking alfuzosin:</p><p>
<i>Rare</i>
</p><ul>
<li>Chest pain</li>
<li>chills</li>
<li>cold sweats</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position</li>
<li>fainting</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>painful or prolonged erection of the penis</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Arm, back, or jaw pain</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>bloody urine</li>
<li>chest discomfort, tightness, or heaviness</li>
<li>clay-colored stools</li>
<li>dark urine</li>
<li>diarrhea</li>
<li>fever</li>
<li>headache</li>
<li>hives, welts, itching, skin rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>pinpoint red spots on the skin</li>
<li>stomach pain</li>
<li>sweating</li>
<li>swelling</li>
<li>unpleasant breath odor</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vomiting of blood</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of alfuzosin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Belching</li>
<li>body aches or pain</li>
<li>congestion</li>
<li>cough</li>
<li>cough producing mucus</li>
<li>decreased interest in sexual intercourse</li>
<li>difficulty breathing</li>
<li>difficulty having a bowel movement</li>
<li>dryness or soreness of the throat</li>
<li>ear congestion</li>
<li>heartburn</li>
<li>hoarseness</li>
<li>inability to have or keep an erection</li>
<li>indigestion</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>loss of voice</li>
<li>nasal congestion</li>
<li>pain</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>sneezing</li>
<li>sore throat</li>
<li>stomach discomfort or upset</li>
<li>stuffy or runny nose</li>
<li>tender, swollen glands in the neck</li>
<li>tightness in the chest</li>
<li>trouble with swallowing</li>
<li>unusual tiredness or weakness</li>
<li>voice changes</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Feeling of warmth</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
</ul><p>
<!-- end oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alfuzosin: oral tablet extended release</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 27%), headache (up to 14%), fatigue (up to 14%)</p>
<p><b>Common</b> (1% to 10%): Syncope, pain</p>
<p><b>Postmarketing reports</b>: Flushing<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 14%)</p>
<p><b>Common</b> (1% to 10%): Bronchitis, sinusitis, pharyngitis</p>
<p><b>Postmarketing reports</b>: Rhinitis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension or postural hypotension</p>
<p><b>Postmarketing reports</b>: Tachycardia, chest pain, angina pectoris in patients with preexisting coronary artery disease, atrial fibrillation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, dyspepsia, constipation, nausea</p>
<p><b>Postmarketing reports</b>: Diarrhea, vomiting<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Impotence </p>
<p><b>Postmarketing reports</b>: Priapism<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Intraoperative Floppy Iris Syndrome (IFIS) has been observed in some patients undergoing phacoemulsification cataract surgery while being treated with alpha-1 blockers<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Hepatocellular and cholestatic liver injury (including cases with jaundice leading to drug discontinuation)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Postmarketing reports</b>: Rash, pruritus, urticaria, angioedema, toxic epidermal necrolysis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Thrombocytopenia</p><h3>Metabolic</h3><p><b>Postmarketing reports</b>: Edema</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Jardin A,  Bensadoun H,  Delauche-Cavallier MC,  Stalla-Bourdillon A,  Attali P "Long-term treatment of benign prostatic hyperplasia with alfuzosin: a 24-30 month survey. BPHALF Group." Br J Urol 74 (1994): 579-84</p><p id="ref_2">2. "Product Information. Xatral (alfuzosin)." Sanofi-Synthelabo Canada Inc, Markham, ON. </p><p id="ref_3">3. "Product Information. Uroxatral (alfuzosin)." sanofi-aventis , Bridgewater, NJ. </p><p id="ref_4">4. Hansen BJ,  Nordling J,  Mensink HJ,  Walter S,  Meyhoff HH "Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group." Scand J Urol Nephrol Suppl 157 (1994): 169-76</p><p id="ref_5">5. Qazi HA,  Ananthakrishnan K,  Manikandan R,  Fordham MV "Stuttering priapism after ingestion of alfuzosin." Urology 68 (2006): 890.e5-6</p><p id="ref_6">6. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_7">7. Wang YS,  Tay YK,  Kwok C "Toxic epidermal necrolysis caused by alfuzosin, an alpha1-adrenoceptor antagonist." Arch Dermatol 142 (2006): 938</p></div>
<div class="more-resources" id="moreResources">
<h2>More about alfuzosin</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>59 Reviews</li>
<li>Drug class: antiadrenergic agents, peripherally acting</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Alfuzosin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Uroxatral</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Benign Prostatic Hyperplasia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to alfuzosin: oral tablet extended release</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 27%), headache (up to 14%), fatigue (up to 14%)</p><p><b>Common</b> (1% to 10%): Syncope, pain</p><p><b>Postmarketing reports</b>: Flushing<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 14%)</p><p><b>Common</b> (1% to 10%): Bronchitis, sinusitis, pharyngitis</p><p><b>Postmarketing reports</b>: Rhinitis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension or postural hypotension</p><p><b>Postmarketing reports</b>: Tachycardia, chest pain, angina pectoris in patients with preexisting coronary artery disease, atrial fibrillation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, dyspepsia, constipation, nausea</p><p><b>Postmarketing reports</b>: Diarrhea, vomiting<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Impotence </p><p><b>Postmarketing reports</b>: Priapism<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Intraoperative Floppy Iris Syndrome (IFIS) has been observed in some patients undergoing phacoemulsification cataract surgery while being treated with alpha-1 blockers<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Hepatocellular and cholestatic liver injury (including cases with jaundice leading to drug discontinuation)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Postmarketing reports</b>: Rash, pruritus, urticaria, angioedema, toxic epidermal necrolysis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Postmarketing reports</b>: Thrombocytopenia</p><h3>Metabolic</h3><p><b>Postmarketing reports</b>: Edema</p><p id="ref_1">1. Jardin A,  Bensadoun H,  Delauche-Cavallier MC,  Stalla-Bourdillon A,  Attali P "Long-term treatment of benign prostatic hyperplasia with alfuzosin: a 24-30 month survey. BPHALF Group." Br J Urol 74 (1994): 579-84</p><p id="ref_2">2. "Product Information. Xatral (alfuzosin)." Sanofi-Synthelabo Canada Inc, Markham, ON. </p><p id="ref_3">3. "Product Information. Uroxatral (alfuzosin)." sanofi-aventis , Bridgewater, NJ. </p><p id="ref_4">4. Hansen BJ,  Nordling J,  Mensink HJ,  Walter S,  Meyhoff HH "Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group." Scand J Urol Nephrol Suppl 157 (1994): 169-76</p><p id="ref_5">5. Qazi HA,  Ananthakrishnan K,  Manikandan R,  Fordham MV "Stuttering priapism after ingestion of alfuzosin." Urology 68 (2006): 890.e5-6</p><p id="ref_6">6. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_7">7. Wang YS,  Tay YK,  Kwok C "Toxic epidermal necrolysis caused by alfuzosin, an alpha1-adrenoceptor antagonist." Arch Dermatol 142 (2006): 938</p><h2>More about alfuzosin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>59 Reviews</li>
<li>Drug class: antiadrenergic agents, peripherally acting</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Alfuzosin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Benign Prostatic Hyperplasia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>